Deltasone and Remodulin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Deltasone (prednisone) and Remodulin (treprostinil sodium). Common drug interactions include nausea among females and device related infection among males.

The phase IV clinical study analyzes what interactions people have when they take Deltasone and Remodulin. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Deltasone?

Deltasone has active ingredients of prednisone. eHealthMe is studying from 4,243 Deltasone users. Check the latest studies of Deltasone.

What is Remodulin?

Remodulin has active ingredients of treprostinil sodium. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,843 Remodulin users. Check the latest studies of Remodulin.

On Jul, 16, 2026

47 people who take Deltasone and Remodulin together, and have interactions are studied.

Deltasone and Remodulin drug interactions.

What are the common drug interactions of Deltasone and Remodulin, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Weight increased
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Infection
Epistaxis (bleed from the nose)
Dyspnoea exertional (breathlessness or shortness of breath)
Cardiac failure congestive
Pulmonary hypertension (increase in blood pressure in the lung artery)
Dyspepsia (indigestion)
Infusion site swelling

male:

Device related infection
Intervertebral disc protrusion (spinal disc protrusion)
Septic shock (shock due to blood infection)

What are the common drug interactions of Deltasone and Remodulin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Pneumonia
Anxiety
Chest pain
Cough
Dyspnoea (difficult or laboured respiration)
Malaise (a feeling of general discomfort or uneasiness)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Oropharyngeal pain
Pain
Pleurisy (inflammation of the pleurae, which causes pain when breathing)

30-39:

Epistaxis (bleed from the nose)
Weight decreased
Fatigue (feeling of tiredness)
Haematocrit decreased
Haemoglobin decreased
Right ventricular failure (right half of the heart fails to work)
Chest pain
Dyspnoea (difficult or laboured respiration)
Anaemia (lack of blood)
Pulmonary hypertension (increase in blood pressure in the lung artery)

40-49:

Back pain
Chest pain
Dyspepsia (indigestion)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Nausea (feeling of having an urge to vomit)
Pain
Vomiting
Acute respiratory failure
Anaemia (lack of blood)
Cardiac failure congestive

50-59:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Acetonaemia (acetone bodies in the blood)
Death
Diabetic coma
Disease progression
Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Ketonuria (ketones in urine)
Presyncope

60+:

Acute respiratory failure
Dyspnoea (difficult or laboured respiration)
Infusion site discomfort
Infusion site erythema (reddening of the skin at infusion site)
Infusion site infection
Infusion site pain
Infusion site swelling
Oral candidiasis (fungal infection of mouth)
Pneumonia
Pulmonary oedema (fluid accumulation in the lungs)

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 23 people, 48.94%
Dyspnea (difficult or laboured breathing): 8 people, 17.02%
High Blood Cholesterol: 6 people, 12.77%
Diarrhea: 6 people, 12.77%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 5 people, 10.64%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 10.64%
Pain: 5 people, 10.64%
Osteoporosis (bones weak and more likely to break): 5 people, 10.64%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 10.64%
Wheezing (a high-pitched whistling sound made while you breath): 4 people, 8.51%

* Approximation only. Some reports may have incomplete information.

Do you take Deltasone and Remodulin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously